Reading view
“Not just hot water”: marine heatwaves can create toxic relationship between seagrasses and microbes
Aircraft measurements reveal surprisingly strong Southern Ocean biological productivity
Struggle sleeping? These three common sleep habits tied to signs of brain aging, study finds
Error correction tech boosts the 3D printing of big composite parts
Salesforce Plans 133 Layoffs in Washington, California
Salesforce on Wednesday told state government agencies in Washington and California that it plans to permanently layoff 133 employees at the start of October
Some 74 employees will be cut in San Francisco, California, the company’s headquarters, while 59 will be laid off in Bellevue and Seattle, ...
Figma, Canva Showing Growing Pains of AI Pivot
Welcome back!
Software companies have been at pains to flaunt the success of their AI products, as they seek to dispel investor fears that AI apps are threatening their existence. Two reports this week show that developing popular AI products is only half the challenge.
Canva, the design software company popular among students and business owners, warned investors this week that its annual revenue growth would slow to 20%. The reason: it was tapping the brakes on a planned AI rollout expected to drive paying subscriptions—after demand had proved higher and more expensive to serve than anticipated.
Then on Thursday, Figma said it expects a slowdown in revenue growth for the September quarter, to 36% from 48% in June. In its case, the publicly traded design software company suggested it’s still figuring out how to generate sales from new AI tools that are still in beta, or testing phases, or early in their release.
Atlassian Stock Soars on Strong Cloud Revenue Growth
Atlassian shares soared as much as 38% in after-hours trading on Thursday after the enterprise software company reported its first quarterly operating profit in more than two years. Atlassian CEO and cofounder Mike Cannon-Brookes said he planned to start buying as much as $250 million in shares, ...
<i>FNIP1</i> variants are associated with favourable metabolism in 1 million humans
Nature, Published online: 05 August 2026; doi:10.1038/s41586-026-10864-2
The FNIP1 pathway has a role in human energy metabolism, and its inhibition is a potential therapeutic strategy in cardiometabolic disease.The three-and-beyond-body problem: juggling kids, travel and careers in academia
Nature, Published online: 04 August 2026; doi:10.1038/d41586-026-01845-6
The issues faced by scientist-couples can be multiplied once they start a family, making conference travel a logistical trial.